Evidence map›Paper›PMID 37743659›Full record

ArticleRNA biology2023

Characterization of CoCas9 nuclease from

A Vasileva, P Selkova, A Arseniev, M Abramova, N Shcheglova, O Musharova, I Mizgirev, T Artamonova, M Khodorkovskii, K Severinov and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RNA biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

A VasilevaCenter of Nanobiotechnology, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia.
P SelkovaCenter of Nanobiotechnology, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia.
A ArsenievCenter of Nanobiotechnology, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia.
M AbramovaCenter of Nanobiotechnology, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia.
N ShcheglovaCenter of Nanobiotechnology, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia.
O MusharovaComplex of NBICS Technologies, National Research Center "Kurchatov Institute", Moscow, Russia.
I MizgirevLaboratory of Carcinogenesis and Aging, N.N. Petrov National Medical Research Center of Oncology, St. Petersburg, Russia.
T ArtamonovaCenter of Nanobiotechnology, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia.
M KhodorkovskiiCenter of Nanobiotechnology, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia.
K SeverinovComplex of NBICS Technologies, National Research Center "Kurchatov Institute", Moscow, Russia.
I FedorovaCenter of Nanobiotechnology, Peter the Great St. Petersburg Polytechnic University, St. Petersburg, Russia.ORCID 0000-0001-6144-173X
Peter the Great St. Petersburg Polytechnic University · RUGenesis Foundation · USKurchatov Institute · RURutgers, The State University of New Jersey · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cas9 nucleases are widely used for genome editing and engineering. Cas9 enzymes encoded by CRISPR-Cas defence systems of various prokaryotic organisms possess different properties such as target site preferences, size, and DNA cleavage efficiency. Here, we biochemically characterized CoCas9 from

Indexed as

CRISPR-Associated Protein 9CRISPR-Cas SystemsCapnocytophagaGene EditingHumansCRISPR-Associated Protein 9Capnocytophaga ochraceaCas9CoCas9CRISPR-CasRNA-guided nuclease

Identifiers

PMID37743659
PMCPMC10521337
OpenAlexW4387003066

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.